L-131-2022

Agreement ID
L-131-2022
Lead IC
NIAID
Exclusivity
Nonexclusive
External Party
Ceva Sante Animale S.A.
Fiscal Year
2023
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-2717     Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine
TAB-3336     Substitutions-Modified Prefusion RSV F Proteins and Their Use